These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31415723)

  • 41. [Botulinum toxin type A for the treatment of spasticity in children with cerebral palsy].
    Dimitrijević L; Stanković I; Zivković V; Mikov A; Colović H; Janković I
    Vojnosanit Pregl; 2007 Aug; 64(8):513-8. PubMed ID: 17874717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin for the treatment of spasticity in children: attainment of treatment goals.
    Weigl DM; Arbel N; Katz K; Becker T; Bar-On E
    J Pediatr Orthop B; 2007 Jul; 16(4):293-6. PubMed ID: 17527109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy-A Secondary Analysis of the Randomized Clinical Trial.
    Hong BY; Chang HJ; Lee SJ; Lee S; Park JH; Kwon JY
    Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28825663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective results with botulinum toxin in cerebral palsy.
    Coutinho dos Santos LH; Bufara Rodrigues DC; Simões de Assis TR; Bruck I
    Pediatr Neurol; 2011 May; 44(5):357-63. PubMed ID: 21481744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serial Casting as an Adjunct to Botulinum Toxin Type A Treatment in Children With Cerebral Palsy and Spastic Paraparesis With Scissoring of the Lower Extremities.
    Dai AI; Demiryürek AT
    J Child Neurol; 2017 Jun; 32(7):671-675. PubMed ID: 28393669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy.
    Desloovere K; Molenaers G; De Cat J; Pauwels P; Van Campenhout A; Ortibus E; Fabry G; De Cock P
    Dev Med Child Neurol; 2007 Jan; 49(1):56-61. PubMed ID: 17209978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
    Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
    J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
    Copeland L; Edwards P; Thorley M; Donaghey S; Gascoigne-Pees L; Kentish M; Cert G; Lindsley J; McLennan K; Sakzewski L; Boyd RN
    J Pediatr; 2014 Jul; 165(1):140-146.e4. PubMed ID: 24630348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of botulinum toxin type A treatment in children with cerebral palsy: Sequential physical changes for 3 months after the injection.
    Matsuda M; Tomita K; Yozu A; Nakayama T; Nakayama J; Ohguro H; Iwasaki N
    Brain Dev; 2018 Jun; 40(6):452-457. PubMed ID: 29510955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
    Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
    Boyd RN; Hays RM
    Eur J Neurol; 2001 Nov; 8 Suppl 5():1-20. PubMed ID: 11851730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experience with botulinum toxin in the treatment of cerebral palsy.
    Arens LJ; Leary PM; Goldschmidt RB
    S Afr Med J; 1997 Aug; 87(8):1001-3. PubMed ID: 9323408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscle histopathology in children with spastic cerebral palsy receiving botulinum toxin type A.
    Valentine J; Stannage K; Fabian V; Ellis K; Reid S; Pitcher C; Elliott C
    Muscle Nerve; 2016 Mar; 53(3):407-14. PubMed ID: 26154631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional improvement in cerebral palsy patients treated with botulinum toxin A injections - preliminary results.
    Sławek J; Klimont L
    Eur J Neurol; 2003 May; 10(3):313-7. PubMed ID: 12752407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of physiotherapeutic intervention on the gait after the application of botulinum toxin in children with cerebral palsy: systematic review.
    Fonseca PR; Calhes Franco de Moura R; Galli M; Santos Oliveira C
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):757-765. PubMed ID: 29185676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of botulinum toxin A and abduction bracing on long-term hip development in children with cerebral palsy.
    Willoughby K; Ang SG; Thomason P; Graham HK
    Dev Med Child Neurol; 2012 Aug; 54(8):743-7. PubMed ID: 22686491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Influence of toxin botulin on walk stereotype of children with juvenile cerebral palsy. The functional examination performed by BTS, comprehensive movement analysis system. A preliminary report].
    Kwiecień-Czerwieniec I; Krukowska J; Woldańska-Okońska M
    Wiad Lek; 2014; 67(2 Pt 1):59-63. PubMed ID: 25764777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.